Inflammatory Bowel Disease Cohort in Nantes
Observational · No treatment assigned · 3 sites · Nantes University Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patients over 18 years of age;
- Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
- Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
Plus 1 more requirement(s). There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 360 participants are expected to take part.
- Start date: 2025-02-04.
- Main results expected around 2028-02 (estimate from the record).
- 3 study sites listed (1 marked recruiting) in France.
Main thing being measured
- Proportion of patients who succeed in their therapeutic strategy (One year after inclusion)
In the researchers’ words
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases |
| Lead sponsor | Nantes University Hospital |
| Enrollment | 360 (estimated) |
| Start date | 2025-02-04 |
| Primary completion (est.) | 2028-02 |
| First posted | 2024-02-13 |
| Last updated | 2025-02-10 |
| Official title | Cohorte Nantaise de Maladies Inflammatoires Chroniques Intestinales |
| ClinicalTrials.gov ID | NCT06256393 |
Interventions
- Collection of biological samples (Other)
Collection of blood samples and intestinal biopsies during a surgery or colonoscopy for disease relapse
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients over 18 years of age; * Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis; * Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy; * Patients who have given written consent to participate in the study and to keep biological samples for research purposes Exclusion Criteria: * Patients refusing to participate in the cohort; * Patients with chronic inflammatory bowel disease quiescent at inclusion; * Patients with a contraindication to general anaesthesia; * Vulnerable patients (under court protection, curators, guardians);
Locations (3)
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Nantes | Nantes | France | Recruiting |
| Clinique Jules Verne | Nantes | France | Not yet recruiting |
| Hopital Privé du Confluent | Nantes | France | Not yet recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.